On November 28, YRPG released its first “Environmental, Social and Governance (ESG) Report” at the 2nd Biopharmaceutical Supply Chain Conference. This marks the Group’s first external disclosure of its annual environmental protection, social responsibility, and governance achievements. The report covers multiple aspects such as quality management, green and low-carbon transformation, and social welfare, systematically reviewing and summarizing YRPG’s ESG practices and accomplishments for 2023.
Solution
-
Medicine
- Alimentary Tract and Metabolism
- Antiinfectives for Systemic Use
- Antineoplastic and Immunomodulating Agents
- Blood and Blood Forming Organs
- Cardiovascular System
- Dermatologicals
- Genit Ourinary System and Sex Hormones
- Musculo-Skeletal System
- Nervous System
- Respiratory System
- Sensory Organs
- Systemic Hormonal Preparations, Excl. Sex Hormones and Insulins
- Various
- CMO